Health

Low- and No-Calorie Artificial Sweeteners Intake Linked to Cognitive Decline

A Brazilian longitudinal cohort study suggested that consumption of low- and no-calorie sweeteners (LNCSs) was associated with accelerated cognitive decline. A total of 12,772 civil servants (mean age 52 years, 55% women) were followed over three study waves across eight years. Using dietary questionnaires and cognitive testing, researchers found that younger participants (<60 years) consuming higher amounts of LNCSs had a faster decline in verbal fluency and global cognition, with artificial LNCSs (aspartame, saccharin, acesulfame K) and sugar alcohols (erythritol, sorbitol, xylitol) particularly linked to declines in memory and verbal fluency. The associations were seen in both participants with and without diabetes, though patterns differed by subgroup. No associations were observed in participants aged 60+. The findings raised concerns about potential long-term effects of artificial sweeteners on brain health. Source: https://www.neurology.org/

hyangiu

Recent Posts

Egg Consumption Linked to Lower Alzheimer’s Risk

A US prospective study found that moderate egg consumption was associated with a significantly lower…

2 days ago

Primary Care Approaches to Anxiety: CBT and SSRIs/SNRIs Lead Effective Treatment

Anxiety disorders are common yet often underrecognized in primary care, but a review shows that…

7 days ago

Recombinant Zoster Vaccination Linked to Reduced Risk of Dementia in Older Adults

Two-dose recombinant zoster vaccination (RZV) was associated with a significantly lower risk of new-onset dementia,…

1 week ago

Colonoscopy Screening Reduced Colorectal Cancer Incidence but No Significant Mortality Benefit

A 13-year follow-up of a randomized controlled trial found that a single colonoscopy screening significantly…

1 week ago

Ultra-Processed Food Intake Linked to Poorer Attention and Higher Dementia Risk

Higher consumption of ultra-processed foods (UPFs) is associated with poorer attention and increased modifiable dementia…

2 weeks ago

BP-Lowering Reduces Cardiovascular Risk Across All CKD Stages, with Attenuated Benefit in Diabetes

Blood pressure (BP)-lowering treatment significantly reduces the risk of major cardiovascular events in individuals with…

2 weeks ago

This website uses cookies.